Tracking Risks of Kidney Failure in Older Patients with Severe CKD
Increased risks of severe CKD in elderly don’t always translate into increased mortality...
Nephrology Newsletter
SGLT2i Shown to Reduce Mortality in CKD
DAPA-CKD finds benefit in CKD patients with and without T2D Continuing the steady flow of positive...
Alpha Blockers for Treatment of Ureteric Stones
Alpha blockers are a class of pharmacological agents that restrict the hormone norepinephrine from tightening the muscles in walls of smaller veins and arteries. The objective of this study is to assess the safety and efficacy...
Genetic modifiers of long-term survival in sickle cell anemia.
Sickle cell anemia (SCA) is a clinically heterogeneous, monogenic disorder. Medical care has less-than-optimal impact on clinical outcomes in SCA in Africa due to several factors, including patient accessibility, poor access to...
COVID-19 in Grade 4-5 Chronic Kidney Disease Patients.
Chronic kidney disease (CKD) increases the risk of mortality during coronavirus disease 2019 (COVID-19) episodes, and some reports have underlined the high incidence and severity of this infection in dialysis patients....
Dialysis Patients Want CPR, But at What Cost?
Study finds their desire for resuscitation does not align with their advance directives According...
Post-Heart Transplant Osteoporosis & Chronic Kidney Disease
“Recipients of heart transplantation (HT) require immunosuppression to prevent organ rejection,”...
Oral Roxadustat in CKD Patients with Anemia
Roxadustat acts as a HIF prolyl-hydroxylase inhibitor and increases the endogenous production of erythropoietin and stimulates the production of hemoglobin in red blood cells. The objective of this study is to evaluate the...
Systolic BP with Risk of Incident CKD
Chronic kidney disease (CKD) and hypertension are closely associated with each other. A few studies suggest that in addition to hypertension, temporal trends in systolic BP could be a potential risk factor of kidney function...
Vitamin K Supplementation to Improve Vascular Stiffness in CKD
Arterial or vascular stiffness can be an indicator of vascular calcification in patients with chronic kidney disease (CKD). Vitamin K is a cofactor that could prevent vascular calcification and the subsequent risk of...
Distal Diuretics vs. Dietary Sodium Restriction for Hypertension in CKD
Hypertension can either be the cause or the effect of chronic kidney disease (CKD). In either case, controlling hypertension is essential to slow down the disease progression and reduce CVD risk. Distal diuretics are a potential...
Outcomes of Canagliflozin by Baseline Kidney Function
Canagliflozin is an oral medication that helps control blood sugar levels by helping kidneys get rid of glucose from your bloodstream. Besides, the mediation also aids in reducing cardiovascular and renal events in patients with...
